Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Gamma for Post-aggressive Immunosuppression in ICU
NCT06694740Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2026
- Primary completion
- Mar 2029
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon gamma-1b in immunosuppression, sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2026; status: recruiting.
02
Drugs
interferon gamma-1b
03
Conditions
immunosuppression
Beyond the preview
Go deeper on NCT06694740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06694740.